NCT03244384
Clinical Trial Information
Trial Number: NCT03244384 (ClinicalTrials.gov)
Disease Type:
- Urothelial Tract Neoplasm - Miscellaneous
Trial Title:
"Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation"
Study ID:
A031501
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®